Award
National Cancer Institute 5R01CA258421-05
Gold-derived therapeutic compounds for disease application
Recipient
Samuel Gorman Awuah
Award Amount
$336,989.00
Ceiling
$336,989.00
Awarded
August 05, 2025
Identifier
5R01CA258421-05
NIH grant awarded to develop and evaluate gold-based therapeutic compounds for cancer treatment, focusing on triple-negative breast cancer.
Description
This is a NIH grant award for research on gold-derived compounds targeting mitochondrial function for cancer therapy, specifically for triple-negative breast cancer (TNBC). The project aims to develop targeted gold-based drugs, elucidate their mechanisms, and evaluate their efficacy in mouse models.